Although the GIP and GIP receptor system is known to promote energy assimilation and contribute to obesity [26], the fact that a dual GIP/GLP-1R agonist exhibited stronger anti-obesity effects than GLP-1RAs alone was unexpected. The gene discussed is GIP; the disease is obesity disorder.